CatalystWireBeta

Genus

GNS · Main Market · Health Care · mcap £1,490m · 2288.0p

Beta Briefing, track record and signals & risks are not ready for Genus yet.

We follow 964 UK small caps and every one of their announcements – often hundreds per company. 73 companies are already wired into a briefing: browse them.

Key announcements Monitoring checked today, 06:35

DateTypeAnnouncementDay
09 Oct 26 Results Annual Report and Annual General Meeting
Annual Report 2026 and Notice of AGM sent to shareholders; AGM scheduled for 18 November 2026.
+2.6%
10 Sep 26 Share Buyback Programme
Genus announces £60 million share buyback programme expected to conclude in H2 FY27.
−3.3%
10 Sep 26 Results Final Results
FY26 adjusted PBT grew 35% to £100.2m; £60m buyback announced; PIC China joint venture formed.
−3.3%
14 Jul 26 Trading update FY26 Trading Update – Ahead of expectations
FY26 results ahead of consensus at £98m adjusted PBT; net leverage reduced to 0.4x after £111m BCA cash received.
+3.7%
04 Mar 26 Director Declaration
Genus plc (LSE: GNS) today announces that Lysanne Gray, Non-Executive Director, has been appointed as a Non-Executive Director of Johnson Service Group plc, a FTSE 250 listed company that provides textile rental and rela
−2.1%
26 Feb 26 Results Half-year Results
H1 25 adjusted operating profit increased 38% to £55.8m; formed Chinese porcine joint venture post-period
−10.4%
02 Feb 26 Successful formation of Chinese porcine JV
Genus completes formation of Chinese porcine joint venture with Beijing Capital Agribusiness, receiving US$160m gross cash.
−6.2%
23 Jan 26 PRP Regulatory Progress – Canada
Canada approves PRP gene edit for PRRS-resistant pigs; further approvals needed in Mexico, Japan and China.
+0.5%
16 Jan 26 Trading update Half Year Trading Update – Ahead of expectations
H1 FY26 adjusted profit before tax approximately £50m excluding BCA milestone, ahead of expectations.
+7.8%
19 Nov 25 Result of AGM
Genus plc (the 'Company') - 2025 AGM Poll Results
+8.8%
19 Nov 25 Board change Non-Executive Director Appointments
Dr Celia Baxter appointed Non-Executive Director effective 19 November 2025; Dr Robert Reiter appointed effective 1 January 2026.
+8.8%
19 Nov 25 Trading update AGM Trading Update
Genus reports strong start to FY26 with PIC growth across all regions; Group profit expected modestly ahead of market midpoint.
+8.8%

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note